Client stories

Helping a global biopharmaceutical company meet its bold ambitions for over a quarter of the world’s population

Life Sciences, LS Access & Sustainability, Strategy & Customer

Our client is a global biopharmaceutical company. Its purpose is to unite science, technology and talent to positively impact the health of 2.5 billion people by the end of 2030 and reduce the impact of antimicrobial resistance (AMR) through the prevention and treatment of priority infectious diseases.

What was the challenge​?

Our client lacked a clearly articulated and aligned approach to AMR. The existing approach was fragmented, with no clear point of accountability and lack of visibility of AMR activities across the business. Our client wanted support understanding the current state of AMR activity, identifying gaps in the existing approach and outlining potential AMR related opportunities to explore further.

How we helped​?

We adopted a tailored approach and worked closely with our client to:

  • Undertake desktop research to draw out insights from previously executed work and provide context to support questioning during stakeholder interviews
  • Conduct interviews with key internal stakeholders to fully understand the scope of the client’s AMR activities and highlight any gaps and opportunities in the existing approach
  • Plan and lead workshops to draw out further insights regarding gaps and opportunities, using a framework to focus opportunity discussions around the aspirational future state, delivering a more strategic approach to identify and prioritise opportunities
  • Consolidate insights into a report which provided strategic recommendations and next steps to facilitate the progression of the existing approach
  • Act as a thought partner to the client, to guide the evolution of our client’s currently fragmented AMR approach to a more strategic and aligned approach across the business.

What was the impact?

Using our trademark partnership approach and applying our usual expertise, energy and imagination we:

  • Provided a clear view of the current AMR pipeline and activities across the business, allowing the client to fully understand their ‘as-is’
  • Developed a comprehensive yet digestible report highlighting key gaps, opportunities and tangible next steps to provide the client with clear direction as to how to successfully progress their current approach.

Our client is now better placed to get ahead of disease, meet its bold ambitions for patients, new commitments to growth and deliver a step-change in performance.

We’re always here to help

Leo Koshutova

Partner, Lead
Life Sciences

Email me